CLINICAL BENEFITS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN A CONTEMPORARY COHORT OF AT-RISK PATIENTS

被引:0
|
作者
Daher, Darine
El Dahan, Karim Seif
Rich, Nicole E.
Tayob, Nabihah
Merrill, Vincent
Huang, Daniel
Yang, Ju Dong
Kulkarni, Anand V.
Kanwal, Fasiha
Marrero, Jorge A.
Parikh, Neehar D.
Singal, Amit G.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1544
引用
收藏
页码:S1723 / S1723
页数:1
相关论文
共 50 条
  • [21] Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
    Parikh, Neehar D.
    Tayob, Nabihah
    Al-Jarrah, Taim
    Kramer, Jennifer
    Melcher, Jennifer
    Smith, Donna
    Marquardt, Patrick
    Liu, Po-Hong
    Tang, Runlong
    Kanwal, Fasiha
    Singal, Amit G.
    JAMA NETWORK OPEN, 2022, 5 (07) : E2223504
  • [22] Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers
    Lisa X. Deng
    Neil Mehta
    Digestive Diseases and Sciences, 2020, 65 : 3456 - 3462
  • [23] Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers
    Deng, Lisa X.
    Mehta, Neil
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (12) : 3456 - 3462
  • [24] SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA: A CLINICAL AUDIT
    Townsend, S. A.
    Ch'ng, C. L.
    GUT, 2012, 61 : A413 - A413
  • [25] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN A PROSPECTIVE COHORT OF 446 AMERICAN PATIENTS WITH CIRRHOSIS UNDERGOING SURVEILLANCE
    Singal, Amit
    Conjeevaram, Hari S.
    Fontana, Robert J.
    Fu, Sherry
    Wright, Whitney
    Askari, Fred
    Su, Grace L.
    Lok, Anna S.
    Marrero, Jorge A.
    HEPATOLOGY, 2009, 50 (04) : 1075A - 1076A
  • [26] CLINICAL SIGNIFICANCE OF TUMOR MARKERS IN SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS: A MULTICENTER PROSPECTIVE COHORT STUDY IN JAPAN
    Uchino, Koji
    Tateishi, Ryosuke
    Fujiwara, Naoto
    Mitsuhiko, Moriyama
    Eguchi, Yuichiro
    Toyoda, Hidenori
    Ida, Yoshiyuki
    Karino, Yoshiyasu
    Kudo, Masatoshi
    Chuma, Makoto
    Takuma, Yoshitaka
    Kaneko, Shuichi
    Kato, Naoya
    Chayama, Kazuaki
    Izumi, Namiki
    Itoi, Takao
    Sakaida, Isao
    Komeda, Hideyuki
    Umemura, Takeji
    Ishikawa, Toru
    Nakamuta, Makoto
    Takaki, Akinobu
    Terai, Shuji
    Ido, Akio
    Enomoto, Nobuyuki
    Yoshida, Hitoshi
    Baba, Toshiyuki
    Torimura, Takuji
    Hiasa, Yoichi
    Ogawa, Chikara
    Takehara, Tetsuo
    Kumada, Takashi
    Koike, Kazuhiko
    HEPATOLOGY, 2019, 70 : 225A - 226A
  • [27] NATURAL HISTORY OF CIRRHOSIS IN A COHORT OF PATIENTS UNDERGOING STRUCTURED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA: RESULTS FROM THE ABERDEEN SURVEILLANCE COHORT
    Lalwani, S.
    Mukhopadhya, A.
    Fraser, A.
    Hold, G. L.
    Bailey, L.
    Vijayan, B.
    English, S.
    Mcleman, L.
    GUT, 2016, 65 : A158 - A159
  • [28] Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis
    Nguyen, Mindie H.
    Roberts, Lewis R.
    Engel-Nitz, Nicole M.
    Bancroft, Tim
    Ozbay, A. Burak
    Singal, Amit G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (12) : 2163 - 2173
  • [29] POPULATION-BASED CLINICAL COHORT ALLOWS MAPPING OF HEPATOCELLULAR CARCINOMA INCIDENCE AND RISK FACTORS TO ENABLE TARGETED SURVEILLANCE
    Hong, T. P.
    Gow, P.
    Fink, M.
    Dev, A.
    Roberts, S.
    Nicoll, A.
    Lubel, J.
    Kronborg, I.
    Arachchi, N.
    Ryan, M.
    Kemp, W.
    Knight, V.
    Farrugia, H.
    Thursfield, V.
    Desmond, P.
    Thompson, A. J.
    Bell, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S342 - S342
  • [30] Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma
    Christian Rabe
    Tillmann Pilz
    Christoph Klostermann
    Marc Berna
    Hans H.Schild
    Tilman Sauerbruch
    Wolfgang H.Caselmann
    World Journal of Gastroenterology, 2001, (02) : 208 - 215